Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alector, Inc. stock logo
ALEC
Alector
$1.50
+2.0%
$2.77
$0.87
$6.14
$148.78M0.994.06 million shs6.64 million shs
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$1.35
+2.3%
$1.42
$0.77
$5.80
$316.60M0.7129.32 million shs17.93 million shs
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$10.00
+0.7%
$8.33
$6.57
$105.00
$323.98M1.05182,293 shs94,318 shs
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
$1.96
+1.6%
$1.75
$0.89
$4.07
$82.91M1.08184,032 shs206,712 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alector, Inc. stock logo
ALEC
Alector
+2.04%-50.66%-52.53%-14.77%-67.88%
Canopy Growth Corporation stock logo
CGC
Canopy Growth
+2.27%+3.05%-4.93%+18.42%-73.21%
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
+0.70%+6.72%+23.15%+20.77%+999,999,900.00%
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
+1.55%+7.10%+13.62%+25.64%-42.86%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alector, Inc. stock logo
ALEC
Alector
$1.50
+2.0%
$2.77
$0.87
$6.14
$148.78M0.994.06 million shs6.64 million shs
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$1.35
+2.3%
$1.42
$0.77
$5.80
$316.60M0.7129.32 million shs17.93 million shs
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$10.00
+0.7%
$8.33
$6.57
$105.00
$323.98M1.05182,293 shs94,318 shs
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
$1.96
+1.6%
$1.75
$0.89
$4.07
$82.91M1.08184,032 shs206,712 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alector, Inc. stock logo
ALEC
Alector
+2.04%-50.66%-52.53%-14.77%-67.88%
Canopy Growth Corporation stock logo
CGC
Canopy Growth
+2.27%+3.05%-4.93%+18.42%-73.21%
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
+0.70%+6.72%+23.15%+20.77%+999,999,900.00%
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
+1.55%+7.10%+13.62%+25.64%-42.86%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alector, Inc. stock logo
ALEC
Alector
1.82
Reduce$3.00100.00% Upside
Canopy Growth Corporation stock logo
CGC
Canopy Growth
1.25
Strong SellN/AN/A
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
2.60
Moderate Buy$19.0090.00% Upside
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
2.20
Hold$4.50129.59% Upside

Current Analyst Ratings Breakdown

Latest RPTX, CGC, ALEC, and JBIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/24/2025
Alector, Inc. stock logo
ALEC
Alector
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/24/2025
Canopy Growth Corporation stock logo
CGC
Canopy Growth
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$10.00 ➝ $5.00
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformMarket Perform
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOverweightNeutral
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOutperformNeutral$1.50
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformNeutral$1.50
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyNeutral
10/22/2025
Alector, Inc. stock logo
ALEC
Alector
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuyHold
10/9/2025
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$28.00
(Data available from 10/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alector, Inc. stock logo
ALEC
Alector
$100.56M1.51N/AN/A$1.29 per share1.16
Canopy Growth Corporation stock logo
CGC
Canopy Growth
$225.65M1.43N/AN/A$1.90 per share0.71
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
N/AN/AN/AN/A$92.88 per shareN/A
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
$53.48M1.57N/AN/A$3.56 per share0.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alector, Inc. stock logo
ALEC
Alector
-$119.05M-$1.16N/AN/AN/A-142.10%-112.06%-26.37%11/5/2025 (Estimated)
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$429.86M-$3.03N/AN/AN/A-155.76%-89.93%-44.24%11/7/2025 (Estimated)
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
-$69.63M-$30.33N/AN/AN/A-51.96%-47.65%N/A
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
-$84.69M-$2.58N/AN/AN/AN/A-78.25%-66.85%11/6/2025 (Estimated)

Latest RPTX, CGC, ALEC, and JBIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/7/2025Q2 2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.11N/AN/AN/A$71.82 millionN/A
11/6/2025Q3 2025
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
-$0.49N/AN/AN/A$7.50 millionN/A
11/5/2025Q3 2025
Alector, Inc. stock logo
ALEC
Alector
-$0.40N/AN/AN/A$3.49 millionN/A
8/13/2025Q2 2025
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
-$0.43-$0.86-$0.43-$0.86N/AN/A
8/8/2025Q1 2026
Canopy Growth Corporation stock logo
CGC
Canopy Growth
-$0.15-$0.14+$0.01-$0.16$64.98 million$52.98 million
8/8/2025Q2 2025
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
-$0.56-$0.39+$0.17-$0.39$2.50 million$0.25 million
8/7/2025Q2 2025
Alector, Inc. stock logo
ALEC
Alector
-$0.45-$0.30+$0.15-$0.30$2.76 million$7.87 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alector, Inc. stock logo
ALEC
Alector
N/AN/AN/AN/AN/A
Canopy Growth Corporation stock logo
CGC
Canopy Growth
N/AN/AN/AN/AN/A
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
N/AN/AN/AN/AN/A
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alector, Inc. stock logo
ALEC
Alector
0.13
3.78
3.78
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.59
3.07
2.12
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
N/A
10.31
10.31
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
N/A
6.30
6.30

Institutional Ownership

CompanyInstitutional Ownership
Alector, Inc. stock logo
ALEC
Alector
85.83%
Canopy Growth Corporation stock logo
CGC
Canopy Growth
3.33%
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
N/A
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
85.09%

Insider Ownership

CompanyInsider Ownership
Alector, Inc. stock logo
ALEC
Alector
9.70%
Canopy Growth Corporation stock logo
CGC
Canopy Growth
0.16%
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
24.90%
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
11.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alector, Inc. stock logo
ALEC
Alector
270101.21 million91.39 millionOptionable
Canopy Growth Corporation stock logo
CGC
Canopy Growth
3,150239.85 million239.47 millionOptionable
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
2032.63 million24.50 millionN/A
Repare Therapeutics Inc. stock logo
RPTX
Repare Therapeutics
18042.96 million38.02 millionOptionable

Recent News About These Companies

Repare (RPTX) Q2 Loss Narrows 52%
Repare Therapeutics Inc. (RPTX) - Yahoo Finance
Repare inks licensing deal with Debiopharm for lunresertib
Repare Therapeutics Inc (RPTX) - Investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alector stock logo

Alector NASDAQ:ALEC

$1.50 +0.03 (+2.04%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$1.48 -0.01 (-1.00%)
As of 10/24/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, an immune activity in the brain with genetic links to multiple neurodegenerative disorders, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California.

Canopy Growth stock logo

Canopy Growth NASDAQ:CGC

$1.35 +0.03 (+2.27%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$1.34 -0.01 (-0.37%)
As of 10/24/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

Jade Biosciences stock logo

Jade Biosciences NASDAQ:JBIO

$10.00 +0.07 (+0.70%)
As of 10/24/2025 04:00 PM Eastern

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Repare Therapeutics stock logo

Repare Therapeutics NASDAQ:RPTX

$1.96 +0.03 (+1.55%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$1.93 -0.03 (-1.58%)
As of 10/24/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validate, and build a pipeline of SL-based therapeutics that focuses on genomic instability, including DNA damage repair. The company's lead product candidate is Camonsertib (RP-3500), an oral small molecule inhibitor under Phase ½ development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing Lunresertib (RP-6306), a PKMYT1 Inhibitor, which is under Phase 1 clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; RP-1664, an oral PLK4 inhibitor, under Phase 1 clinical trial designed to harness the synthetic lethal relationship with TRIM37 amplification or overexpression in solid tumors; and RP-3467, a polymerase theta adenosinetriphosphatase (ATPase) inhibitor, a SL target associated with BRCA mutations and other genomic alterations. The company has license and collaboration agreement with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; New York University; and Ono Pharmaceutical Co., as well as a clinical study and collaboration agreement with Debiopharm to explore the synthetic lethal combination of PKMYT1 and WEE1 inhibition in cancer. Repare Therapeutics Inc. was incorporated in 2016 and is headquartered in Montréal, Canada.